Business
PsyKey Inc. Announces Letter of Intent with MycoVita Canada to Form Strategic Partnership for Advanced Mycology Product Development.
PsyKey Inc. Announces Letter of Intent with MycoVita Canada to Form Strategic Partnership for Advanced Mycology Product Development..
About this update from Cecors, Inc.
[{"type":"text","content":"CECORS, INC. (OTC PINK: CEOS) (\"CeCors\" or the \"Company\"), is pleased to announce that its wholly owned Canadian subsidiary PsyKey Inc. has entered into a letter of intent with MycoVita Canada Inc. (“MycoVita”) to form a strategic partnership. The PsyKey – MycoVita strategic partnership will focus on the research, development, and commercialization of Mycology based formulations, products, and therapeutics, including exploring scientific and research-based approaches in regards to psilocybin and its uses as a potential therapeutic.MycoVita, whose name is derived from Latin meaning “mushroom life\" is a Biotech company focused on the development of functional foods and products that support optimal health and wellbeing through science backed formulations and research. Mushrooms and their derived bio-products offer unique benefits for both the body and mind, ranging from immune support, cognition and memory enhancement, to energy and stamina boost. MycoVita is targeting these areas to deliver measurable results for healthy outcomes.MycoVita was founded by Dr. Omon Isikhuemhen who is currently a leading mushroom science and fungal biotechnology professor at the North Carolina A&T State University. Dr. Isikhuemhen credentials include a Bachelor of Science with honors, a Masters of Science in Botany, as well as a Ph.D in Microbiology. Dr. Isikhuemhen is a trail blazer in research and development that has resulted in many technological advancements, products, and numerous scientific publications.“The synergies of the PsyKey – MycoVita strategic partnership are truly exciting. Having the opportunity to partner with a company founded by a world class mycologist, whose goals and ambitions align with those of ours, will provide us with significant advantages as we continue to execute our growth and expansion strategy in the fast-evolving market for mycology based products and therapeutics,” said Amar Bhatal, president of CeCors Inc. “We look forward to announcing more about our exciting planned products and additional business developments in the near future.”For further information: Publicly traded company (OTC Pink: CEOS)Website: www.psykeyworld.comE-mail: [email protected] Follow us on Twitter: https://twitter.com/PsyKeyworldForward-Looking Statements: Safe Harbour Statement - In addition to historical information, this...